The stock drop appears fueled, in part, by an online reporter’s disclosure of the stock selloff and a marketing campaign funded by the biotech firm, Galena Biopharma Inc (NASDAQ:GALE). The campaign to woo investors may have crossed a line by not revealing who paid for it, some observers say. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $4.30 in last session, and closed at $3.73, while the day range of GALE stock is $3.15 – $4.36. The stock showed a negative weekly performance of -24.34%.
Although Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) had a rough 2013 because of a series of FDA setbacks, the company is back on track. Over the past 3 months, shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) have climbed by roughly 255 percent thanks to several positive developments and takeout chatter. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $8.80, in last session and closed at $8.65, by losing -0.12%. The 52 week range of ARIA is $2.15 – $23.00. Company’s market capitalization is $1.61billion.
Shares of Chelsea Therapeutics International Ltd (NASDAQ: CHTP) have been volatile throughout Friday, halting three times on a circuit breaker before 11:35 a.m. EST. Investors are positioning themselves ahead of a very important PDUFA date for Northera (droxidopa), expected out sometime Friday afternoon. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock decreased -4.25% and finished the last session at $4.73. The EPS of the stock remained -0.20. Company’s market capitalization is $370.99million.
J.C. Penney Co. Inc. (NYSE:JCP)’s plan to develop land around its Texas headquarters could generate $200 million, according to an analysis of property records and a project estimate. J.C. Penney Company, Inc. (NYSE:JCP) stock opened the session at $6.03, and closed the session at $6.14. The 52 week range of the JCP stock remained $4.90 – $23.10 and the day range was $5.95 – $6.26.
Leave a Reply